Pancreatic Cancer Research

ResearcherTongji UniversityNo recent work listed

Congying Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4747-6212; OpenAlex author ID A5101951054. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers

Papers 10

  1. Retraction Note: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-023-02595-3↗
  2. Erratum: Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine. Co-author PMID 38074805↗
  3. GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression. First author DOI 10.3389/fcell.2021.640391↗
  4. Identification of Sox6 as a regulator of pancreatic cancer development. Co-author DOI 10.1111/jcmm.13470↗
  5. Thalidomide inhibits proliferation and epithelial-mesenchymal transition by modulating CD133 expression in pancreatic cancer cells. Co-author DOI 10.3892/ol.2017.7213↗
  6. Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine. Co-author PMID 29312502↗
  7. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Co-author DOI 10.1016/j.canlet.2015.12.002↗
  8. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-016-0301-7↗
  9. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer. Co-author DOI 10.1016/j.biopha.2015.05.020↗
  10. Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface. Co-author DOI 10.3892/or.2015.3960↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guoyong Hu · 7 shared papers, 2016–2023 · strength 0.70
  2. Lijuan Yang · 6 shared papers, 2015–2023 · strength 0.59
  3. Rong Wan · 7 shared papers, 2015–2023 · strength 0.58
  4. Weiliang Jiang · 5 shared papers, 2015–2021 · strength 0.41
  5. Li Huang · 2 shared papers, 2023 · strength 0.36
  6. Xingpeng Wang · 4 shared papers, 2016–2023 · strength 0.36
  7. Li Huang · 3 shared papers, 2016–2018 · strength 0.21
  8. Lijuan Yang · 1 shared paper, 2021 · strength 0.17
  9. Yue Zeng · 1 shared paper, 2023 · strength 0.17
  10. Qiong-Ying Yuan · 1 shared paper, 2018 · strength 0.08
  11. Lijuan Yang · 1 shared paper, 2018 · strength 0.08
  12. Bin Hu · 1 shared paper, 2016 · strength 0.05
  13. Maochun Tang · 1 shared paper, 2015 · strength 0.05
  14. Yingying Lu · 1 shared paper, 2015 · strength 0.05
  15. Yan Fang Zhao · 1 shared paper, 2015 · strength 0.05
  16. Hua Liu · 1 shared paper, 2015 · strength 0.05
  17. Feng Wang · 1 shared paper, 2015 · strength 0.05
  18. Xiaohua Jiang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.